Compare BDL & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDL | DRIO |
|---|---|---|
| Founded | 1959 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.2M | 60.6M |
| IPO Year | 1995 | 2013 |
| Metric | BDL | DRIO |
|---|---|---|
| Price | $33.00 | $7.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | 1.8K | ★ 6.7K |
| Earning Date | 05-18-2026 | 05-14-2026 |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | 49.72 | ★ 1559.02 |
| EPS | ★ 1.98 | 1.25 |
| Revenue | ★ $205,248,000.00 | $7,394,000.00 |
| Revenue This Year | N/A | $20.27 |
| Revenue Next Year | N/A | $47.58 |
| P/E Ratio | $16.67 | ★ $6.08 |
| Revenue Growth | 8.99 | ★ 43.02 |
| 52 Week Low | $26.33 | $0.38 |
| 52 Week High | $35.98 | $17.74 |
| Indicator | BDL | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 52.12 | 44.41 |
| Support Level | $29.63 | $7.29 |
| Resistance Level | $33.69 | $9.46 |
| Average True Range (ATR) | 1.02 | 0.39 |
| MACD | 0.16 | -0.04 |
| Stochastic Oscillator | 60.18 | 29.78 |
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.